SCHEMBL2569706

SCHEMBL2569706

CN1CCc2ccc(NC(=O)[C@H](N)CNC(=O)c3ccccc3)cc2CC1

nearest known ligand 0.50

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 1/20 0.50
TP53 P04637 1/20 0.50
GAA P10253 1/20 0.50
NFKB1 P19838 1/20 0.50
HTT P42858 1/20 0.50
RAB9A P51151 1/20 0.50
NFKB2 Q00653 1/20 0.50
RELA Q04206 1/20 0.50
SMN1; SMN2 Q16637 1/20 0.50
TMPRSS2 O15393 1/20 0.48
ROCK2 O75116 13/20 0.47
ROCK1 Q13464 1/20 0.47
CYP3A4 P08684 1/20 0.45
PRMT5 O14744 3/20 0.45
WDR77 Q9BQA1 3/20 0.45
HSD17B3 P37058 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2569655 0.85 HPGD (0.41) NPC1HTTRAB9ASMN1; SMN2ROCK2
SCHEMBL2565731 0.83 POLB (0.45) TP53HTTSMN1; SMN2
SCHEMBL2571876 0.82 ROCK2 (0.48) NPC1TP53RAB9ATMPRSS2ROCK2
SCHEMBL3036150 0.80 F10 (0.46) TMPRSS2ROCK2
SCHEMBL2567344 0.80 NPC1 (0.48) NPC1TP53GAANFKB1HTT
SCHEMBL2567223 0.78 HRH3 (0.47) NPC1RAB9ATMPRSS2ROCK2CYP3A4
SCHEMBL2570020 0.78 KDM4E (0.48) NPC1HTTRAB9ATMPRSS2ROCK2
SCHEMBL2578923 0.78 KDM4E (0.40) HTTSMN1; SMN2ROCK2CYP3A4
SCHEMBL2570332 0.78 KDM4E (0.47) NPC1HTTRAB9ASMN1; SMN2TMPRSS2
SCHEMBL6295065 0.77 NPC1 (0.66) NPC1TP53GAANFKB1HTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1899330-B9 SUBSTITUTED GLYCINAMIDES HAVING AN ANTITHROMBOTIC AND FACTOR XA-INHIBITING EFFECT BOEHRINGER INGELHEIM INT (DE) 2011-11-09 EP claimed
EP-1899330-B1 SUBSTITUTED GLYCINAMIDES HAVING AN ANTITHROMBOTIC AND FACTOR XA-INHIBITING EFFECT BOEHRINGER INGELHEIM INT (DE) 2010-11-24 EP claimed